These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6797766)

  • 1. [The effect of bromocriptine induced estradiol-17 beta in amenorrhea patients with normoprolactinemia and hyperprolactinemia (author's transl)].
    Kato K; Niibe T; Hosoya N; Watanabe H; Mori T
    Horumon To Rinsho; 1981 Aug; 29(8):931-5. PubMed ID: 6797766
    [No Abstract]   [Full Text] [Related]  

  • 2. Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis.
    Le Roith D; Potashnik G; Glick SM
    Int J Fertil; 1979; 24(2):145-7. PubMed ID: 40911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
    Seppälä M; Unnérus HA; Hirvonen E; Ranta T
    J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
    Rjosk HK; Werder K; Fahlbusch R
    Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):575-87. PubMed ID: 986336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperprolactinemia and primary amenorrhea].
    Grizelj V; Drobnjak P; Simunić V
    Jugosl Ginekol Opstet; 1979; 19(5-6):249-52. PubMed ID: 121935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal changes induced by bromocriptine (CB-154) at the early stage of treatment.
    Strauch G; Valcke JC; Mahoudeau JA; Bricaire H
    J Clin Endocrinol Metab; 1977 Mar; 44(3):588-90. PubMed ID: 576425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An endocrinological study of hyperprolactinemia and its treatment (author's transl)].
    Kimura T; Narita O; Suzuki M; Tomoda Y; Kuwayama A; Kageyama N
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):784-92. PubMed ID: 6787150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperprolactinemia and secondary amenorrhea].
    Vulkov I; Dokumov S; Shterev A
    Akush Ginekol (Sofiia); 1979; 18(5):344-9. PubMed ID: 517699
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolactin and luteal phase defect (author's transl)].
    Mühlenstedt D; Meissner M; Schneider HP
    Geburtshilfe Frauenheilkd; 1979 Jul; 39(7):580-7. PubMed ID: 467952
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
    Yarkoni S; Spitz IM; Ben-David M; Polishuk WZ
    Acta Eur Fertil; 1978 Dec; 9(4):185-8. PubMed ID: 573042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors.
    Lamberts SW; Docter R; De Jong FH; Birkenhäger JC; Kwa HG
    Fertil Steril; 1978 Mar; 29(3):287-90. PubMed ID: 346383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and endocrinological evaluation on the progesterone challenge test for amenorrhoeic women (author's transl)].
    Kusuda M; Nagata Y; Kurano A; Nakamura M; Nakamura G; Tsuda T; Onoue T
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):433-41. PubMed ID: 6785988
    [No Abstract]   [Full Text] [Related]  

  • 14. [Yellow body function in bromocryptine induced early pregnancy in patients with hyperprolactinemia (author's transl)].
    Smiljanić N; Ciglar S; Podobnik M
    Jugosl Ginekol Opstet; 1981; 21(3-4):65-9. PubMed ID: 6803072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine induced pregnancy in two cases of euprolactinemic hypothalamic amenorrhea.
    Nencioni T; Miragoli A; Dorato F; Polvani F
    J Endocrinol Invest; 1978 Jan; 1(1):65-7. PubMed ID: 114566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

  • 17. PRL action on E2 ovarian secretion.
    Polatti F; Nava C; Brambilla A; Zara C
    Clin Exp Obstet Gynecol; 1982; 9(3):160-4. PubMed ID: 6819897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The present state of hormonal investigation in amenorrhoea (author's transl)].
    Combes R; Jaquet P; Guibout M; Angeletti S; Tramoni M
    J Gynecol Obstet Biol Reprod (Paris); 1979; 8(1):27-34. PubMed ID: 381368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
    Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
    Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperprolactinemia with prolonged amenorrhea reversed with bromocriptine in a menopausal woman.
    Goldman M; Steinberger A; Ganti S
    Am J Obstet Gynecol; 1988 Jan; 158(1):117-8. PubMed ID: 3122579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.